Literature DB >> 26408913

Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter.

Xuyi Yue1, Christopher Bognar1, Xiang Zhang1, Gregory G Gaehle1, Stephen M Moerlein1, Joel S Perlmutter1, Zhude Tu2.   

Abstract

Automated production of a promising radiopharmaceutical (-)-(1-(8-(2-[(18)F]fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-piperidin-4-yl)(4-fluorophenyl)methanone ([(18)F]VAT) for the vesicular acetylcholine transporter(VAChT) was achieved using a two-step procedure in a current Good Manufacturing Practices fashion. The production of [(18)F]VAT was accomplished in approximately 140 min, with radiochemical yield of ~15.0% (decay corrected), specific activity>111 GBq/µmol, radiochemical purity>99% and mass of VAT ~3.4 μg/batch (n>10). The radiopharmaceutical product meets all quality control criteria for human use, and is suitable for clinical PET studies of VAChT.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Automation; Clinical studies; Fluorine-18; Positron emission tomography; Vesicular acetylcholine transporter

Mesh:

Substances:

Year:  2015        PMID: 26408913      PMCID: PMC4681605          DOI: 10.1016/j.apradiso.2015.09.010

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  21 in total

Review 1.  PET radioligands for the vesicular acetylcholine transporter (VAChT).

Authors:  Nicolas Giboureau; Ian Mat Som; Aurélie Boucher-Arnold; Denis Guilloteau; Michael Kassiou
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

2.  A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations.

Authors:  B H Mock; W Winkle; M T Vavrek
Journal:  Nucl Med Biol       Date:  1997-02       Impact factor: 2.408

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 4.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

5.  In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.

Authors:  Myria Petrou; Kirk A Frey; Michael R Kilbourn; Peter J H Scott; David M Raffel; Nicolaas I Bohnen; Martijn L T M Müller; Roger L Albin; Robert A Koeppe
Journal:  J Nucl Med       Date:  2014-01-30       Impact factor: 10.057

6.  Synthesis and evaluation of vesamicol analog (-)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter.

Authors:  Kazunori Kawamura; Kazuhiro Shiba; Hideo Tsukada; Shingo Nishiyama; Hirofumi Mori; Kiichi Ishiwata
Journal:  Ann Nucl Med       Date:  2006-07       Impact factor: 2.668

7.  Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).

Authors:  M R Marien; S M Parsons; C A Altar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.

Authors:  Zhude Tu; Simon M N Efange; Jinbin Xu; Shihong Li; Lynne A Jones; Stanley M Parsons; Robert H Mach
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

9.  Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles.

Authors:  M L Gilmor; N R Nash; A Roghani; R H Edwards; H Yi; S M Hersch; A I Levey
Journal:  J Neurosci       Date:  1996-04-01       Impact factor: 6.167

10.  Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.

Authors:  Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Phillip Sherman; Carole Quesada; Kirk A Frey; Robert A Koeppe
Journal:  Nucl Med Biol       Date:  2009-05-08       Impact factor: 2.408

View more
  6 in total

1.  Kinetic modeling of [18 F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain.

Authors:  Hongjun Jin; Xuyi Yue; Hui Liu; Junbin Han; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

2.  Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate.

Authors:  Xuyi Yue; Hongjun Jin; Hui Liu; Zonghua Luo; Xiang Zhang; Kota Kaneshige; Hubert P Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  Org Biomol Chem       Date:  2017-06-21       Impact factor: 3.876

Review 3.  PET Imaging in Movement Disorders.

Authors:  Baijayanta Maiti; Joel S Perlmutter
Journal:  Semin Nucl Med       Date:  2018-08-16       Impact factor: 4.446

4.  Radiosynthesis and evaluation of a fluorine-18 labeled radioligand targeting vesicular acetylcholine transporter.

Authors:  Xuyi Yue; Zonghua Luo; Hui Liu; Kota Kaneshige; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Bioorg Med Chem Lett       Date:  2018-09-24       Impact factor: 2.823

5.  Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain.

Authors:  Zonghua Luo; Hui Liu; Hongjun Jin; Jiwei Gu; Yanbo Yu; Kota Kaneshige; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  ChemMedChem       Date:  2018-08-19       Impact factor: 3.466

6.  Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation.

Authors:  Xuyi Yue; Dhruva D Dhavale; Junfeng Li; Zonghua Luo; Jialu Liu; Hao Yang; Robert H Mach; Paul T Kotzbauer; Zhude Tu
Journal:  Bioorg Med Chem Lett       Date:  2018-02-16       Impact factor: 2.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.